SMARCB1 and rhabdoid tumor: Recently, in our study of a kidney-derived SMARCB1-null rhabdoid cancer cell line, we reported that BRG1, a synthetic lethal target in rhabdoid cancer cells, actively remodels chromatin at select enhancer regions, and that this remodeling profoundly influences gene expression [18].